3 days ago
13
During the exhibition, Tsingke showcased its core offerings including:
- End-to-End synthesis tools, such as the Syn-HCY Series (12P/192P/768B), delivering high-throughput oligo production for CRISPR, IVD, and research needs
- GMP production system, featuring the Syn-HL12 synthesizer capable of 200 nmol to 12 mmol scale, equipped with real-time monitoring for UV, pH, and conductivity
- Application coverage across ASO/siRNA therapeutics, gene editing, mRNA vaccine templates, and diagnostic probes
- Over 300 chemical modifications and a robust raw material supply chain supporting batch-to-batch consistency
Visitors were particularly impressed by Tsingke's automation capabilities and flexible modular equipment designed to support high-purity, long-chain, and highly modified oligonucleotide synthesis. The company's ability to integrate reagents, instruments, and services into a unified platform drew significant attention from pharmaceutical and biotech partners.
Get the latest news
delivered to your inbox
Sign up for The Manila Times newsletters
By signing up with an email address, I acknowledge that I have read and agree to the Terms of Service and Privacy Policy.
Tsingke Biotech remains committed to empowering life sciences and therapeutic innovation by building a world-class platform for nucleic acid synthesis.
For inquiries or collaboration, please contact us at [email protected]
Visit: www.tsingke.com
